This document refers to optometrists who have been trained to work in the field of glaucoma but who do not have a specialist qualification. It does not relate to optometrists with no training in the field.
Glaucoma Research Foundation Announces New Evidence For The Cause Of Vision Loss In Glaucoma
January is National Glaucoma Awareness Month and the Glaucoma Research Foundation today announced that novel new findings about the underlying cause of glaucoma have been published in the Proceedings of the National Academy of Sciences (Early Edition a…
Alkeus and Columbia University enter license agreement for potential therapies for dry-AMD, Stargardt disease
Alkeus Pharmaceuticals and Columbia University announced today that they have entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerati…
Alkeus Pharmaceuticals Licenses Novel Ophthalmologic Therapies From Columbia University With Applications In Dry-AMD And Stargardt’s Disease
Alkeus Pharmaceuticals and Columbia University announced today that they have entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerati…
Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells To Treat Age-Related Macular Degeneration
Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a leader in the field of regenerative medicine, announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to treat Dry Age-Related M…
Anti-Bacterial Effects Of Impregnating Plastics With Carbon Dioxide
Everyone has heard that carbon dioxide is responsible for global warming. But the gas also has some positive characteristics. Researchers are now impregnating plastics with compressed CO2 in a process that could lead to new applications ranging from co…